Literature DB >> 19259110

Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia.

Wenlei Jiang1, Paul Desjardins, Roger F Butterworth.   

Abstract

It has been proposed that proinflammatory mechanisms are involved in the pathogenesis of brain edema in acute liver failure (ALF). The aim of this study was to assess the contribution of cerebral inflammation to the neurologic complications of ALF and to assess the antiinflammatory effect of mild hypothermia. Upregulation of CD11b/c immunoreactivity, consistent with microglial activation, was observed in the brains of ALF rats at coma stages of encephalopathy. Interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) mRNAs were increased two to threefold in the brains of ALF rats compared with that in sham-operated controls. The magnitude of increased expression of proinflammatory cytokines in the brain was correlated with the progression of encephalopathy and the onset of brain edema. Significant increases in IL-1beta, IL-6, and TNF-alpha levels were also found in the sera and cerebrospinal fluid (CSF) of these animals. Mild hypothermia delayed the onset of encephalopathy, prevented brain edema, and concomitantly attenuated plasma, brain, and CSF proinflammatory cytokines. These results show that experimental ALF leads to increases in brain production of proinflammatory cytokines, and afford the first direct evidence that central inflammatory mechanisms play a role in the pathogenesis of the cerebral complications of ALF. Antiinflammatory agents could be beneficial in the management of these complications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19259110     DOI: 10.1038/jcbfm.2009.18

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  42 in total

Review 1.  Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2015-11-02       Impact factor: 3.584

2.  Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase.

Authors:  Natalia Qvartskhava; Philipp A Lang; Boris Görg; Vitaly I Pozdeev; Marina Pascual Ortiz; Karl S Lang; Hans J Bidmon; Elisabeth Lang; Christina B Leibrock; Diran Herebian; Johannes G Bode; Florian Lang; Dieter Häussinger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

Review 3.  Therapeutic hypothermia as a bridge to transplantation in patients with fulminant hepatic failure.

Authors:  Luis Castillo; Guillermo Bugedo; Max Rovegno
Journal:  Rev Bras Ter Intensiva       Date:  2015-03-01

Review 4.  Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure.

Authors:  Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2014-07-09

Review 5.  Brain edema in acute liver failure: mechanisms and concepts.

Authors:  Kakulavarapu V Rama Rao; Arumugam R Jayakumar; Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2014-02-25       Impact factor: 3.584

Review 6.  Neuroinflammation in hepatic encephalopathy: mechanistic aspects.

Authors:  Arumugam R Jayakumar; Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  J Clin Exp Hepatol       Date:  2014-08-05

7.  TGR5 signaling reduces neuroinflammation during hepatic encephalopathy.

Authors:  Matthew McMillin; Gabriel Frampton; Richard Tobin; Giuseppina Dusio; Jenny Smith; Hope Shin; Karen Newell-Rogers; Stephanie Grant; Sharon DeMorrow
Journal:  J Neurochem       Date:  2015-09-10       Impact factor: 5.372

Review 8.  Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 9.  Hypothermia as a cytoprotective strategy in ischemic tissue injury.

Authors:  Xian N Tang; Midori A Yenari
Journal:  Ageing Res Rev       Date:  2009-10-13       Impact factor: 10.895

10.  Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats.

Authors:  Ricardo Valladares; Dhyana Sankar; Nan Li; Emily Williams; Kin-Kwan Lai; Asmaa Sayed Abdelgeliel; Claudio F Gonzalez; Clive H Wasserfall; Joseph Larkin; Desmond Schatz; Mark A Atkinson; Eric W Triplett; Josef Neu; Graciela L Lorca
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.